Navigation Links
Ruboxistaurin As A Novel Treatment For Diabetic Nephropathy

Recent research, which appears in the current issue of Diabetes Care, establishes Ruboxistaurin as a promising novel treatment that may improve upon established therapies for diabetic nephropathy//.

Nephropathy is known to develop in 40% of people with type 2 diabetes and is the leading cause of end-stage renal disease in the U.S. and the developed world.

Many persons with diabetes have progressive nephropathy even with the established therapies. Therefore, treatments targeting novel pathogenic mechanisms may be beneficial.

Studies have shown an important role for protein kinase C (PKC)-? in the pathogenesis of diabetic nephropathy. Ruboxistaurin selectively inhibits protein kinase C-? and ameliorates kidney disease in animal models of diabetes.

The study was performed to evaluate the effects of 32mg/day ruboxistaurin for 1 year in persons with type 2 diabetes and persistent albuminuria persistent albuminuria (albumin-to-creatinine ratio [ACR] 200-2,000 mg/g), despite therapy with renin-angiotensin system inhibitors. The primary end point was a change in the ACR. Estimated glomerular filtration rate (eGFR) was also calculated.

It was found that after one year, urinary ACR decreased significantly in participants treated with ruboxistaurin and nonsignificantly in the placebo group. The ACR-lowering effect of ruboxistaurin appeared by 1 month. eGFR did not decline significantly in the ruboxistaurin group, whereas the placebo group lost significant eGFR over 1 year.

Between-group differences for changes in ACR and eGFR were not statistically significant, but this pilot study was underpowered to determine such differences.

The study authors conclude that ruboxistaurin had favorable effects on albuminuria and renal function in persons with type 2 diabetes and nephropathy. The albuminuria-lowering effect occurred early and was sustained long term. Those treated with ruboxista
'"/>




Page: 1 2

Related medicine news :

1. Ruboxistaurin (RBX) may prevent vision loss in diabetic patients
2. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
3. Novel biopsy technique for prostate cancer
4. Novel computer model for breast cancer
5. Novel research on liver cancer
6. Novel way to fight cancer
7. Novel test for bowel cancer
8. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
9. Novel Therapy for Chronic Problem
10. Blood Sugar Kept In Control By Novel Protein
11. Novel antibiotic dressing developed for improved wound healing
Post Your Comments:
(Date:7/25/2008)...hip Based on Significant Improvements in Members, ...r, Inc., a leader in health,care quality managemen...announced it has entered into a long-term agreemen...ark,s Collaboration on Quality(SM) Incent and,Rewa...een Wellmark and,primary care clinicians to promot...
(Date:7/25/2008)...., July 25 /PRNewswire/ -- Sagent Pharmaceuticals,...ompany, today announced that it,has launched amiod...ic,indicated for the treatment and prophylaxis of ...hemodynamically unstable ventricular,tachycardia -...eat.,Sagent,s amiodarone HCl injection will be ava...
(Date:7/25/2008)...t ALS Therapy Alliance to be presented at Fenway P...OCKET, R.I., July 25 /PRNewswire/ -- CVS/pharmacy ...ord-breaking $4.4 million in just 21 days,through ...esearch. This is,the seventh year of the annual fu...han $15 million for ALS research. This year,s fund...
(Date:7/25/2008)...ack-up in esophagus can cause immune system change...- The first evidence linking gastroesophageal refl...y Duke University Medical Center researchers. ,...st noted in the 1970s, and since then studies have...sthma patients also experience GERD symptoms. But ...
Breaking Medicine News(10 mins):Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:People With GERD More Likely to Develop Asthma 2
...s in Singapore are on the rise and data show that ...ch 954 are dead, 631 are confirmed to have AIDS an... and the Singapore senior minister of health Balaj...e to inform the public that wives of HIV positive ...
...nment which intends to stabilize the rates of HIV ...worth atleast 4.1 US dollars to HIV infected indiv...ned to reduce the rate of HIV infection to below 0...ted population of Vietnam approximates to nearly 8...
...zardous activity is a well-known fact. Now two res...te ban on smoking in that country since it affects...eatments for the same//. University of Otago's As...ck Wilson say that the New Zealand governments nee...
...ed by Austrian researchers at the annual meeting o...cago on Friday say that caffeine has the ability t...e areas in the brain that control this activity. ... quantities in coffee, tea, soft drinks and chocol...
Other Medicine News:
(Date:7/24/2008)...ORK, July 24 /- MacroChem C...ced results of a Phase 2 clinical trial,involving ...nter,open-label efficacy and safety study of EcoN...t of onychomycosis (nail fungus). The composite,pr... cure" defined as,negative mycology (negative fung...
(Date:7/23/2008)... results pending publication in July print edition...able on Web, INDIANAPOLIS, July 23 /...ting the use of N-terminal pro-B-type natriuretic ...f NT-proBNP for risk,stratification in predicting ...in patients treated with non-steroidal anti-inflam...
(Date:7/23/2008)...N, July 23 /- FluoroPharma Inc., a co...ents for the Positron Emission Tomography,(PET) ma..., its novel,Fluorine-18 labeled tracer for myocard...ond cardiovascular product to complete Phase I cli... designed to assess the blood flow in the,heart (m...
(Date:7/23/2008)...LE, July 23 /- Dendreon Cor...expects the Independent Data,Monitoring Committee ...sis,of overall survival relating to the Company,s ...rcinoma Treatment, also known as D9902B) clinical ...he Company,s investigational,active cellular immun...
Breaking Medicine Technology:MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Infection outbreaks on teeth can cause alopecia areata or localized hair loss 6950 1Infection outbreaks on teeth can cause alopecia areata or localized hair loss 6950 2Canceled 3A Homecare Rally in Contra Costa County 6949 1Study Shows Cholera Can be Controlled With Oral Vaccines 6947 1Study Shows Cholera Can be Controlled With Oral Vaccines 6947 2Study Shows Cholera Can be Controlled With Oral Vaccines 6947 3Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 1Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 2Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds 26 Flu 916 3
...7 - Researchers at,the Stanford University School ...their new study indicating that an antidepressant,...avioral disorder,known as compulsive buying, did n...who took it., The medication is escitalopram, a co...and name Lexapro. In the study,researchers found ...
...roduct in,AM-Pharma,s pipeline , BUNNIK, The Nethe...rmaceutical company developing novel therapeutics ...ay announced positive,results in patients with Acu...group of a Phase IIa trial with Alkaline Phosphata... a marker for renal function,improved by 45% (med...
Other Medicine Technology:Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 2Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 3AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 2AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 3
Classic black cast boot with unisex styling
The Multi-Purpose Medical-Surgical Shoe
An enzyme-linked immunosorbent assay for the qualitative and semi-quantitative detection of IgA-class antibodies to Gliadin in human serum. The test system is intended to be used as an aid in the dia
...Xpert System utilizes real-time polymerase chain r...e system is the first to fully automate and integr...ng: sample preparation, DNA amplification and dete...the system provides PCR test results from a raw sa...
Medicine Products: